Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for ip strategy
The validity and value of cell therapy safety protocol inventions (T 1555/23) The validity and value of cell therapy safety protocol inventions (T 1555/23) Reviewed by Dr Rose Hughes on Friday, February 27, 2026 Rating: 5
The reproducibility challenge for advanced therapies (T 0827/23) The reproducibility challenge for advanced therapies (T 0827/23) Reviewed by Dr Rose Hughes on Monday, August 04, 2025 Rating: 5
Why patents matter: Understanding the importance of IP in the pharma industry Why patents matter: Understanding the importance of IP in the pharma industry Reviewed by Dr Rose Hughes on Wednesday, July 23, 2025 Rating: 5
Are AI-discovered drug patents blocking innovation? A response to the Science article Are AI-discovered drug patents blocking innovation? A response to the Science article Reviewed by Dr Rose Hughes on Wednesday, June 25, 2025 Rating: 5
IP implications of the FDA guidance for use of AI in drug development IP implications of the FDA guidance for use of AI in drug development Reviewed by Dr Rose Hughes on Tuesday, June 17, 2025 Rating: 5
Freedom to operate versus patentability in biotech: What the difference is and why it matters Freedom to operate versus patentability in biotech: What the difference is and why it matters Reviewed by Dr Rose Hughes on Sunday, June 08, 2025 Rating: 5
Defining the undefinable: The challenges and opportunities for cell therapy IP Defining the undefinable: The challenges and opportunities for cell therapy IP Reviewed by Dr Rose Hughes on Tuesday, May 13, 2025 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.